keyword
https://read.qxmd.com/read/38638098/the-indirect-costs-of-human-papillomavirus-related-cancer-in-central-and-eastern-europe-years-of-life-lost-and-productivity-costs
#1
JOURNAL ARTICLE
Ugne Sabale, Eugenia Karamousouli, Lazar Popovic, Zoárd Tibor Krasznai, Daniel Harrop, Anne Meiwald, Robert Hughes, Georgie Weston, Goran Bencina
BACKGROUND: Human papilloma virus (HPV) is a common cause of several types of cancer, including head and neck (oral cavity, pharynx, oropharynx, hypopharynx, nasopharynx, and larynx), cervical, vulval, vaginal, anal, and penile cancers. As HPV vaccines are available, there is potential to prevent HPV-related disease burden and related costs. METHOD: A model was developed for nine Central Eastern European (CEE) countries (Bulgaria, Croatia, Czechia, Hungary, Poland, Romania, Serbia, Slovakia, Slovenia)...
April 19, 2024: Journal of Medical Economics
https://read.qxmd.com/read/38636710/re-irradiation-versus-systemic-therapy-for-the-management-of-local-regionally-recurrent-head-and-neck-cancer
#2
JOURNAL ARTICLE
Allen M Chen, Jeremy P Harris, Rupali Nabar, Tjoson Tjoa, Yarah Haidar, William B Armstrong
PURPOSE: The optimal management of local-regionally recurrent head and neck cancer that is not amenable to surgical resection is uncertain. We sought to compare outcomes among patients treated with and without re-irradiation in this setting. METHODS AND MATERIALS: A review of institutional registries identified 65 patients with local-regionally recurrent squamous cell carcinoma of the head and neck who were ineligible for surgery. Forty patients (62 %) opted for re-irradiation with the remaining 25 patients (38 %) undergoing initial systemic therapy alone...
April 16, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38636708/a-multicentric-randomized-controlled-phase-iii-trial-of-adaptive-and-18f-fdg-pet-guided-dose-redistribution-in-locally-advanced-head-and-neck-squamous-cell-carcinoma-artforce
#3
JOURNAL ARTICLE
Anna Liza M P de Leeuw, Jordi Giralt, Yungan Tao, Sergi Benavente, Thanh-Vân France Nguyen, Frank J P Hoebers, Ann Hoeben, Chris H J Terhaard, Lip Wai Lee, Signe Friesland, Roel J H M Steenbakkers, Lisa Tans, Jolien Heukelom, Mutamba T Kayembe, Simon R van Kranen, Harry Bartelink, Coen R N Rasch, Jan-Jakob Sonke, Olga Hamming-Vrieze
BACKGROUND AND PURPOSE: This multicenter randomized phase III trial evaluated whether locoregional control of patients with LAHNSCC could be improved by fluorodeoxyglucose-positron emission tomography (FDG-PET)-guided dose-escalation while minimizing the risk of increasing toxicity using a dose-redistribution and scheduled adaptation strategy. MATERIALS AND METHODS: Patients with T3-4-N0-3-M0 LAHNSCC were randomly assigned (1:1) to either receive a dose distribution ranging from 64-84 Gy/35 fractions with adaptation at the 10thfraction (rRT) or conventional 70 Gy/35 fractions (cRT)...
April 16, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38630775/can-predictive-factors-determine-the-time-to-treatment-initiation-for-oral-and-oropharyngeal-cancer-a-classification-and-regression-tree-analysis
#4
JOURNAL ARTICLE
Débora Rosana Alves Braga Silva Montagnoli, Vitória Ferreira Leite, Yasmim Silva Godoy, Vitória Marçolla Lafetá, Edmilson Antônio Pereira Junior, Akhilanand Chaurasia, Maria Cássia Ferreira Aguiar, Mauro Henrique Nogueira Guimarães Abreu, Renata Castro Martins
This ecological study aimed to identify the factors with the greatest power to discriminate the proportion of oral and oropharyngeal cancer (OOC) records with time to treatment initiation (TTI) within 30 days of diagnosis in Brazilian municipalities. A descriptive analysis was performed on the variables grouped into five dimensions related to patient characteristics, access to health services, support for cancer diagnosis, human resources, and socioeconomic characteristics of 3,218 Brazilian municipalities that registered at least one case of OOC in 2019...
2024: PloS One
https://read.qxmd.com/read/38630576/human-malignancies-associated-with-persistent-hpv-infection
#5
JOURNAL ARTICLE
Alison A McBride
Human papillomavirus (HPV)-associated malignancies account for ~5% of human cancers worldwide. Thirteen, or more, HPV types are oncogenic, but infection with these viruses is common and usually cleared within 2 years. Only infections that become persistent are associated with the development of cancer, often occurring several decades later. These cancers mostly arise in 6 different anatomical regions: 5 are anogenital (anus, cervix, penis, vagina, and vulva) and the sixth is the oropharynx. Oncogenic HPVs promote cellular proliferation and genomic instability, but the anatomical niche of the target tissue also plays an important role in the development of cancer...
April 17, 2024: Oncologist
https://read.qxmd.com/read/38623593/igsf3-tissue-expression-in-squamous-cell-carcinoma-of-the-oropharynx-a-novel-tool-for-prognosis-assessment-in-hpv-related-and-hpv-unrelated-disease
#6
JOURNAL ARTICLE
Anni Sjöblom, Lauri Jouhi, Pirjo Laakkonen, Reija Randén-Brady, Jussi Tarkkanen, Caj Haglund, Petri Mattila, Timo Carpén, Jaana Hagström, Antti Mäkitie
Biomarkers are not broadly used in the management of head and neck cancers (HNCs). Biomarkers have been beneficial in the management of other cancers, however, not in HNCs. Therefore, we observed the immunopositivity of a novel biomarker called immunoglobulin superfamily member 3 (IGSF3) in tumor tissues in HPV-related and HPV-unrelated OPSCC. Two patient cohorts (C1 and C2) from separate time periods were available for this study (total N = 282). Both consisted of OPSCC patients treated at the Helsinki University Hospital (HUS, Helsinki, Finland) during 2000-2016...
April 16, 2024: APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica
https://read.qxmd.com/read/38621326/addressing-positive-multi-cancer-early-detection-tests-in-head-and-neck-surgery-experience-with-head-and-neck-work-up-for-high-risk-referrals
#7
JOURNAL ARTICLE
Forrest W Fearington, Conan Y Zhao, Santiago Romero-Brufau, Eric J Moore, Daniel L Price, Kendall K Tasche, Linda X Yin, Elizabeth T Kunkel, John B Kisiel, Karthik V Giridhar, David M Routman, Kathryn M Van Abel
OBJECTIVES: Blood-based multi-cancer early detection (MCED) tests are now commercially available. However, there are currently no consensus guidelines available for head and neck cancer (HNC) providers to direct work up or surveillance for patients with a positive MCED test. We seek to describe cases of patients with positive MCED tests suggesting HNC and provide insights for their evaluation. METHODS: Retrospective chart review of patients referred to Otolaryngology with an MCED result suggesting HNC...
April 14, 2024: Oral Oncology
https://read.qxmd.com/read/38613196/elective-neck-dissection-in-ct1-4-n0m0-head-and-neck-basaloid-carcinoma
#8
JOURNAL ARTICLE
Aman M Patel, Afash Haleem, Hassaam S Choudhry, Robert M Brody, Jason A Brant, Ryan M Carey
OBJECTIVE: To investigate the survival benefit of elective neck dissection (END) over neck observation in surgically resected cT1-4 N0M0 head and neck basaloid carcinoma (HNBC). STUDY DESIGN: Retrospective cohort study. SETTING: The 2006 to 2017 hospital-based National Cancer Database. METHODS: Patients with surgically resected cT1-4 N0M0 HNBC were selected. Linear, binary logistic, Kaplan-Meier, and Cox proportional hazards regression models were implemented...
April 12, 2024: Otolaryngology—Head and Neck Surgery
https://read.qxmd.com/read/38603656/latin-american-consensus-on-the-treatment-of-head-and-neck-cancer
#9
REVIEW
Leandro Luongo Matos, Luiz Paulo Kowalski, Aline Lauda Freitas Chaves, Thiago Bueno de Oliveira, Gustavo Nader Marta, Maria Paula Curado, Gilberto de Castro Junior, Terence P Farias, Gustavo Sarria Bardales, Mario Avila Cabrera, Renato de Castro Capuzzo, Genival Barbosa de Carvalho, Claudio Roberto Cernea, Rogério Aparecido Dedivitis, Fernando Luiz Dias, Andrés Munyo Estefan, Agustin Horacio Falco, Gustavo Alberto Ferraris, Alejandro Gonzalez-Motta, Andre Guimarães Gouveia, Alexandre Arthur Jacinto, Marco Aurelio Vamondes Kulcsar, Ana Kober Leite, Renan Bezerra Lira, Milena Perez Mak, Pedro De Marchi, Evandro Sobroza de Mello, Fátima Cristina Mendes de Matos, Pablo H Montero, Eduardo Dias de Moraes, Fabio Ynoe de Moraes, Diego Chaves Rezende Morais, Fernando Miguel Poenitz, Adela Poitevin, Hernán Ortiz Riveros, Álvaro Sanabria, Miguel Ticona-Castro, José Guilherme Vartanian, Gustavo Viani, Eugenio F Vines, William Nassib William Junior, David Conway, Shama Virani, Paul Brennan
Head and neck squamous cell carcinoma (HNSCC) is well known as a serious health problem worldwide, especially in low-income countries or those with limited resources, such as most countries in Latin America. International guidelines cannot always be applied to a population from a large region with specific conditions. This study established a Latin American guideline for care of patients with head and neck cancer and presented evidence of HNSCC management considering availability and oncologic benefit. A panel composed of 41 head and neck cancer experts systematically worked according to a modified Delphi process on (1) document compilation of evidence-based answers to different questions contextualized by resource availability and oncologic benefit regarding Latin America (region of limited resources and/or without access to all necessary health care system infrastructure), (2) revision of the answers and the classification of levels of evidence and degrees of recommendations of all recommendations, (3) validation of the consensus through two rounds of online surveys, and (4) manuscript composition...
April 2024: JCO global oncology
https://read.qxmd.com/read/38602686/neoadjuvant-chemotherapy-and-transoral-robotic-surgery-for-oropharynx-cancer-and-quality-of-life-reply
#10
JOURNAL ARTICLE
Nader Sadeghi, Marco Mascarella, Nathaniel Bouganim
No abstract text is available yet for this article.
April 11, 2024: JAMA Otolaryngology—Head & Neck Surgery
https://read.qxmd.com/read/38602684/neoadjuvant-chemotherapy-and-transoral-robotic-surgery-for-oropharynx-cancer-and-quality-of-life
#11
JOURNAL ARTICLE
Jose Granell, Raimundo Gutierrez-Fonseca
No abstract text is available yet for this article.
April 11, 2024: JAMA Otolaryngology—Head & Neck Surgery
https://read.qxmd.com/read/38600434/international-guidelines-for-intratumoral-and-intranodal-injection-of-nbtxr3-nanoparticles-in-head-and-neck-cancers
#12
JOURNAL ARTICLE
Xavier Liem, Thierry de Baère, Omar I Vivar, Tanguy Y Seiwert, Colette Shen, Zsuzsanna Pápai, Victor Moreno, Zoltán Takácsi-Nagy, Frigyes Helferich, Juliette Thariat, Zhen Gooi, Sue S Yom, Paolo Bossi, Robert L Ferris, Trevor G Hackman, Christophe Le Tourneau, Joseph Rodriguez, Caroline Hoffmann
BACKGROUND: An international multidisciplinary panel of experts aimed to provide consensus guidelines describing the optimal intratumoral and intranodal injection of NBTXR3 hafnium oxide nanoparticles in head and neck squamous cell carcinoma (HNSCC) of the oral cavity, oropharynx, and cervical lymph nodes and to review data concerning safety, feasibility, and procedural aspects of administration. METHODS: The Delphi method was used to determine consensus. A 4-member steering committee and a 10-member monitoring committee wrote and revised the guidelines, divided into eight sections...
April 10, 2024: Head & Neck
https://read.qxmd.com/read/38595736/evaluation-of-salivary-tumor-necrosis-factor-%C3%AE-as-a-diagnostic-biomarker-in-oral-submucosal-fibrosis-and-squamous-cell-carcinoma-of-the-oral-cavity-and-oropharynx-a-cross-sectional-observational-study
#13
JOURNAL ARTICLE
Sabiha Abdul Aziz Shaikh, Ceena Denny E, Reshma Kumarchandra, Srikant Natarajan, Johan Sunny, Nandita Shenoy, Nandita K P
INTRODUCTION: Tumor necrosis factor α (TNF-α) is known to be associated with chronic inflammation, and its expression has been shown to increase in advanced cancers. Chronic inflammation is a characteristic feature of oral submucous fibrosis (OSMF), which is a potentially malignant disorder (PMD). Squamous cell carcinoma (SCC) is associated with considerable mortality and morbidity and an early detection or monitoring would greatly help in achieving an effective cure. TNF-α was thus evaluated for use as a biomarker in the present study according to the stage of OSMF and histological grade of SCC in the oral cavity and oropharynx...
2024: Front Oral Health
https://read.qxmd.com/read/38592283/analogies-between-hpv-behavior-in-oral-and-vaginal-cavity-narrative-review-on-the-current-evidence-in-the-literature
#14
REVIEW
Miriam Dellino, Grazia Pinto, Antonio D'Amato, Francesco Barbara, Francesco Di Gennaro, Annalisa Saracino, Antonio Simone Laganà, Antonella Vimercati, Antonio Malvasi, Vito Maurizio Malvasi, Ettore Cicinelli, Amerigo Vitagliano, Eliano Cascardi, Vincenzo Pinto
Human genital papilloma virus infection is the most prevalent sexually transmitted infection in the world. It is estimated that more than 75% of sexually active women contract this infection in their lifetime. In 80% of young women, there is the clearance of the virus within 18-24 months. In developed countries, oral squamous cell carcinoma (OSCC) is now the most frequent human papilloma virus (HPV)-related cancer, having surpassed cervical cancer, and it is predicted that by 2030 most squamous cell carcinomas will be the HPV-related rather than non-HPV-related form...
March 1, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38591659/ctdna-as-an-adjunct-to-posttreatment-pet-for-head-and-neck-cancer-recurrence-risk-assessment
#15
JOURNAL ARTICLE
Saudamini J Lele, Dauren Adilbay, Ellen Lewis, John Pang, Ameya A Asarkar, Cherie-Ann O Nathan
OBJECTIVE: Circulating tumor DNA (ctDNA) detection is an emerging technique that identifies minimal residual disease in patients with solid tumors. ctDNA can act as an adjunct method to help overcome the limitations of positron emission tomography (PET) and select patients who are at high risk for recurrence. STUDY DESIGN: Retrospective Single Institutional Study. SETTING: University Hospital Setting. METHODS: Twenty-nine patients who underwent definitive treatment for squamous cell carcinoma of the head and neck (HNSCC) from 8/2021 to 01/2023 had ctDNA levels analyzed at 1 to 3, 6, 9, and 12 months after definitive treatment...
April 9, 2024: Otolaryngology—Head and Neck Surgery
https://read.qxmd.com/read/38581118/risk-of-recurrence-after-neoadjuvant-chemotherapy-and-transoral-robotic-surgery-in-patients-with-oropharynx-cancer-that-avoid-adjuvant-radiation
#16
JOURNAL ARTICLE
Alisha R Pershad, Punam G Thakkar, Joseph F Goodman, Arjun Joshi, Seth M Steinberg, Clint T Allen, Charalampos S Floudas
BACKGROUND: De-escalation strategies for newly-diagnosed p16-positive oropharyngeal squamous cell carcinoma (p16+ OPSCC), aim to reduce treatment-related morbidity without compromising disease control. One strategy is neoadjuvant cisplatin and docetaxel chemotherapy (NAC + S) before transoral robotic surgery, with pathology-based risk-adapted adjuvant treatment. METHODS: We examined the recurrence-free survival (RFS) for patients who received NAC + S...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38575432/reducing-salivary-toxicity-with-adaptive-radiotherapy-restart-a-randomized-controlled-trial-comparing-conventional-imrt-to-adaptive-imrt-in-head-and-neck-squamous-cell-carcinomas
#17
JOURNAL ARTICLE
S Ghosh Laskar, S Sinha, A Kumar, A Samanta, S Mohanty, S Kale, F Khan, S Lewis Salins, V Murthy
BACKGROUND: The utility of Adaptive Radiotherapy (ART) in Head and Neck Squamous Cell Carcinoma (HNSCC) remains to be ascertained. While multiple retrospective and single-arm prospective studies have demonstrated its efficacy in decreasing parotid doses and reducing xerostomia, adequate randomized evidence is lacking. METHODS AND ANALYSIS: ReSTART (Reducing Salivary Toxicity with Adaptive Radiotherapy) is an ongoing phase III randomized trial of patients with previously untreated, locally advanced HNSCC of the oropharynx, larynx, and hypopharynx...
March 18, 2024: Clinical Oncology: a Journal of the Royal College of Radiologists
https://read.qxmd.com/read/38573201/head-and-neck-cancer-patients-treated-with-concomitant-chemoradiotherapy-involving-the-oral-cavity-and-oropharynx-is-another-choice-possible-than-prophylactic-gastrostomy
#18
REVIEW
Pierre Senesse, Jeanne Briant, Pierre Boisselier, René-Jean Bensadoun, Marie Vinches, Kerstin Faravel
PURPOSE OF REVIEW: Recent recommendations on cachexia highlight, in head and neck cancers, the heterogeneity of studies, focusing on weight loss and sequelae including swallowing disorders. The current national guidelines emphasize that, in cases of concurrent chemoradiotherapy (cCRT) involving the oral cavity and oropharynx, prophylactic gastrostomy placement should be carried out systematically. We review why this technique is particularly relevant in this specific location for the feasibility of cCRT...
May 1, 2024: Current Opinion in Oncology
https://read.qxmd.com/read/38570166/stair-stepped-mandibulotomy-clinical-indication-surgery-program-design-and-operation-points
#19
Shuqi Zhao, Zhengxue Han, Yi Qu
For radical treatment of malignancies in the posterior region of the oral cavity and oropharynx, surgical exposure of the tumor by mandibulotomy is often required. Midline or paramedian vertical mandibulotomies are commonly performed in clinical practice, but these can damage the suprahyoid musculature and genioglossus, and weaken the swallowing and speech function of patients. Stair-stepped mandibulotomy is a new procedure, developed on the principles of functional surgery, that preserves the structure and function of the mandible whilst providing a clear field and avoiding damage to critical muscle attachments...
April 1, 2024: Journal of Stomatology, Oral and Maxillofacial Surgery
https://read.qxmd.com/read/38566759/epidemiological-and-clinical-description-of-patients-with-oropharyngeal-cancer-treated-in-a-public-oncology-referral-hospital-in-chile
#20
JOURNAL ARTICLE
V Felipe Carvajal, M Felipe Cardemil, Beatriz P Vásquez, Carolina E Oliva, Tamra A Barría, Maribel A Bruna, Leonor A Moyano, Felipe A Bustos, Paola A Muñoz, Cristóbal F Araya, Jorge E Oyarzún, Eduardo A Villa, Federico A Floriano, Alexis J Del Rio, Sebastián R Indo, Enrique A Castellón, Héctor R Contreras
INTRODUCTION: The incidence of squamous carcinoma of the oropharynx (OPSCC) has presented an increase worldwide, a fact that occurs along with a phenomenon of epidemiological transition, whose pathogenesis is linked to human papilloma virus (HPV) in a significant part of the cases. Published evidence at the Latin American level is scarce. The present study aims to evaluate the epidemiological and clinical characteristics of patients with oropharyngeal cancer treated in a public oncology reference centre in Chile...
2024: Ecancermedicalscience
keyword
keyword
84176
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.